IShares Nasdaq Biotechnology ETF PE Ratio 1970-1969 | IBB

Current and historical p/e ratio for IShares Nasdaq Biotechnology ETF (IBB) from 1970 to 1969. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. IShares Nasdaq Biotechnology ETF PE ratio as of November 13, 2019 is 0.00.
IShares Nasdaq Biotechnology ETF PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-11-13 110.58 inf
Sector Industry Market Cap Revenue
Finance Finance - Publicly Traded Investment Trusts $7.087B $0.000B
The ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.
Stock Name Country Market Cap PE Ratio
Sea (SE) Singapore $10.138B 0.00
Adams Diversified Equity Fund (ADX) United States $1.746B 0.00
Lifestyle Holdings (LFSYY) Hong Kong, SAR China $1.622B 0.00
Compass Diversified Holdings (CODI) United States $1.343B 16.36
Taiwan Fund (TWN) United States $0.160B 0.00
Equus Total Return (EQS) United States $0.021B 0.00
GSV Capital Corp (SSSS) United States $0.000B 0.00